{"transactions":[{"id":1980034,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":116162,"kind":"person","name":"Huang Alan","position":1,"cik":"0001877364","reported_name":"Huang Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T16:05:23.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":190181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":190181,"derivative":{"exercise_price":5.2,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":190181},"source":{"system":"sec-edgar","filing":"0000899243-23-006728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877364/000089924323006728/doc4.xml","form_type":"4"}},{"id":1980033,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":116162,"kind":"person","name":"Huang Alan","position":1,"cik":"0001877364","reported_name":"Huang Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-02T16:05:23.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":31697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 5, 2024, 1/3 on February 3, 2025 and 1/3 on February 2, 2026 subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":167584,"source":{"system":"sec-edgar","filing":"0000899243-23-006728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877364/000089924323006728/doc4.xml","form_type":"4"}},{"id":2414410,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":116162,"kind":"person","name":"Huang Alan","position":1,"cik":"0001877364","reported_name":"Huang Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T16:30:23.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":9.22,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-22-004603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877364/000089924322004603/doc4.xml","form_type":"4"}},{"id":2602537,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":116162,"kind":"person","name":"Huang Alan","position":1,"cik":"0001877364","reported_name":"Huang Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-16T19:00:41.000Z","date":"2021-08-12","kind":"grant","acquired":true,"shares":169859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":169859,"derivative":{"exercise_price":9.56,"expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":169859},"source":{"system":"sec-edgar","filing":"0000899243-21-033151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877364/000089924321033151/doc4.xml","form_type":"4"}}]}